Robust Anti‐Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy
dc.contributor.author | Kuai, Rui | |
dc.contributor.author | Singh, Priti B. | |
dc.contributor.author | Sun, Xiaoqi | |
dc.contributor.author | Xu, Cheng | |
dc.contributor.author | Hassani Najafabadi, Alireza | |
dc.contributor.author | Scheetz, Lindsay | |
dc.contributor.author | Yuan, Wenmin | |
dc.contributor.author | Xu, Yao | |
dc.contributor.author | Hong, Hao | |
dc.contributor.author | Keskin, Derin B. | |
dc.contributor.author | Wu, Catherine J. | |
dc.contributor.author | Jain, Renu | |
dc.contributor.author | Schwendeman, Anna | |
dc.contributor.author | Moon, James J. | |
dc.date.accessioned | 2020-09-02T14:57:54Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-09-02T14:57:54Z | |
dc.date.issued | 2020-09 | |
dc.identifier.citation | Kuai, Rui; Singh, Priti B.; Sun, Xiaoqi; Xu, Cheng; Hassani Najafabadi, Alireza; Scheetz, Lindsay; Yuan, Wenmin; Xu, Yao; Hong, Hao; Keskin, Derin B.; Wu, Catherine J.; Jain, Renu; Schwendeman, Anna; Moon, James J. (2020). "Robust Anti‐Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy." Advanced Therapeutics 3(9): n/a-n/a. | |
dc.identifier.issn | 2366-3987 | |
dc.identifier.issn | 2366-3987 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/156420 | |
dc.description.abstract | Potent anti‐tumor T cell response and efficient intratumoral T cell infiltration are the major challenges for therapeutic cancer vaccines. To address these issues, a nanovaccine system is designed to promote anti‐tumor T cell responses, and intratumoral infiltration is examined in various murine tumor models. Subcutaneous vaccination with nanodiscs carrying human papillomavirus (HPV)‐16 E7 antigen elicits as high as ∼32% E7‐specific CD8α+ T cell responses in circulation, representing a 29‐fold improvement over the soluble peptide vaccination. Importantly, nanodisc vaccination also promotes robust intratumoral T cell infiltration and eliminates HPV16 E6/E7‐expressing TC‐1 tumors at mucosal sites, including lungs, inner lip, and intravaginal tissues. In a benchmark study with a live Listeria vaccine combined with anti‐PD‐1 IgG, nanodiscs plus anti‐PD‐1 immune checkpoint blockade elicits comparable levels of T cell responses with anti‐tumor efficacy. Furthermore, compared with Complete Freund’s Adjuvant combined with tetanus toxoid, nanodisc vaccination in HLA‐A02 mice generates >200‐fold stronger IFN‐γ+ T cell responses against a neoantigen from an HLA‐A02 melanoma patient. Overall, these results show that the nanodisc system is a promising cancer vaccine platform for inducing anti‐tumor T cell responses.Efficient infiltration of T cells in solid cancer is a major challenge for cancer immunotherapy. A nanoparticle vaccine system is developed to promote T cell infiltration into peripheral mucosal tissues and eliminate disseminated tumors. Nanodiscs are broadly applicable with a wide range of tumor antigens, thus providing a versatile and potent vaccine platform for eliciting T cell immunity. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | neoantigen | |
dc.subject.other | nanoparticles | |
dc.subject.other | cancer vaccine | |
dc.subject.other | papillomavirus | |
dc.title | Robust Anti‐Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Medicine (General) | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156420/3/adtp202000094.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156420/2/adtp202000094-sup-0001-SuppMat.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156420/1/adtp202000094_am.pdf | en_US |
dc.identifier.doi | 10.1002/adtp.202000094 | |
dc.identifier.source | Advanced Therapeutics | |
dc.identifier.citedreference | L. Decrausaz, S. Domingos‐Pereira, M. Duc, M. Bobst, P. Romero, J. T. Schiller, P. Jichlinski, D. Nardelli‐Haefliger, Int. J. Cancer 2011, 129, 762. | |
dc.identifier.citedreference | T. Ura, K. Okuda, M. Shimada, Vaccines 2014, 2, 624. | |
dc.identifier.citedreference | R. Kuai, D. Li, Y. E. Chen, J. J. Moon, A. Schwendeman, ACS Nano 2016, 10, 3015. | |
dc.identifier.citedreference | R. Kuai, X. Sun, W. Yuan, Y. Xu, A. Schwendeman, J. J. Moon, Bioconjugate Chem. 2018, 29, 771. | |
dc.identifier.citedreference | R. Kuai, X. Sun, W. Yuan, L. J. Ochyl, Y. Xu, A. H. Najafabadi, L. Scheetz, M.‐Z. Yu, I. Balwani, A. Schwendeman, J. J. Moon, J. Controlled Release 2018, 282, 131. | |
dc.identifier.citedreference | A. Hildesheim, R. Herrero, S. Wacholder, A. C. Rodriguez, D. Solomon, M. C. Bratti, J. T. Schiller, P. Gonzalez, G. Dubin, C. Porras, S. E. Jimenez, D. R. Lowy, H. P. V. V. T. G. Costa Rican, JAMA, J. Am. Med. Assoc. 2007, 298, 743. | |
dc.identifier.citedreference | J. Mork, A. K. Lie, E. Glattre, G. Hallmans, E. Jellum, P. Koskela, B. Moller, E. Pukkala, J. T. Schiller, L. Youngman, M. Lehtinen, J. Dillner, N. Engl. J. Med. 2001, 344, 1125. | |
dc.identifier.citedreference | R. Kirnbauer, F. Booy, N. Cheng, D. R. Lowy, J. T. Schiller, Proc. Natl. Acad. Sci. USA 1992, 89, 12180. | |
dc.identifier.citedreference | C. L. Trimble, I. H. Frazer, Lancet Oncol. 2009, 10, 975. | |
dc.identifier.citedreference | C. J. Melief, S. H. van der Burg, Nat. Rev. Cancer 2008, 8, 351. | |
dc.identifier.citedreference | S. Peng, J. W. Wang, B. Karanam, C. Wang, W. K. Huh, R. D. Alvarez, S. I. Pai, C. F. Hung, T. C. Wu, R. B. Roden, PLoS One 2015, 10, 116389. | |
dc.identifier.citedreference | L. Decrausaz, A. R. Goncalves, S. Domingos‐Pereira, C. Pythoud, J. C. Stehle, J. Schiller, P. Jichlinski, D. Nardelli‐Haefliger, Int. J. Cancer 2011, 128, 2105. | |
dc.identifier.citedreference | F. Sandoval, M. Terme, M. Nizard, C. Badoual, M. F. Bureau, L. Freyburger, O. Clement, E. Marcheteau, A. Gey, G. Fraisse, C. Bouguin, N. Merillon, E. Dransart, T. Tran, F. Quintin‐Colonna, G. Autret, M. Thiebaud, M. Suleman, S. Riffault, T. C. Wu, O. Launay, C. Danel, J. Taieb, J. Richardson, L. Zitvogel, W. H. Fridman, L. Johannes, E. Tartour, Sci. Transl. Med. 2013, 5, 172ra20. | |
dc.identifier.citedreference | M. Mondini, M. Nizard, T. Tran, L. Mauge, M. Loi, C. Clemenson, D. Dugue, P. Maroun, E. Louvet, J. Adam, C. Badoual, D. Helley, E. Dransart, L. Johannes, M. C. Vozenin, J. L. Perfettini, E. Tartour, E. Deutsch, Mol. Cancer Ther. 2015, 14, 1336. | |
dc.identifier.citedreference | S. Domingos‐Pereira, L. Decrausaz, L. Derre, M. Bobst, P. Romero, J. T. Schiller, P. Jichlinski, D. Nardelli‐Haefliger, Mucosal Immunol. 2013, 6, 393. | |
dc.identifier.citedreference | D. Nardelli‐Haefliger, J. C. Dudda, P. Romero, Sci. Transl. Med. 2013, 5, 172fs4. | |
dc.identifier.citedreference | L. Bialkowski, A. van Weijnen, K. Van der Jeught, D. Renmans, L. Daszkiewicz, C. Heirman, G. Stange, K. Breckpot, J. L. Aerts, K. Thielemans, Sci. Rep. 2016, 6, 22509. | |
dc.identifier.citedreference | M. I. van Poelgeest, M. J. Welters, R. Vermeij, L. F. Stynenbosch, N. M. Loof, D. M. Berends‐van der Meer, M. J. Lowik, I. L. Hamming, E. M. van Esch, B. W. Hellebrekers, M. van Beurden, H. W. Schreuder, M. J. Kagie, J. B. Trimbos, L. M. Fathers, T. Daemen, H. Hollema, A. R. Valentijn, J. Oostendorp, J. H. Oude Elberink, G. J. Fleuren, T. Bosse, G. G. Kenter, T. Stijnen, H. W. Nijman, C. J. Melief, S. H. van der Burg, Clin. Cancer Res. 2016, 22, 2342. | |
dc.identifier.citedreference | Y. Liu, L. Xu, Y. Jiang, J. Sun, X. He, Cell. Mol. Immunol. 2007, 4, 431. | |
dc.identifier.citedreference | M. Yadav, S. Jhunjhunwala, Q. T. Phung, P. Lupardus, J. Tanguay, S. Bumbaca, C. Franci, T. K. Cheung, J. Fritsche, T. Weinschenk, Z. Modrusan, I. Mellman, J. R. Lill, L. Delamarre, Nature 2014, 515, 572. | |
dc.identifier.citedreference | J. Qiu, L. Yan, J. Chen, C. Y. Chen, L. Shen, N. L. Letvin, B. F. Haynes, N. Freitag, L. Rong, J. T. Frencher, D. Huang, X. Wang, Z. W. Chen, Clin. Vaccine Immunol. 2011, 18, 640. | |
dc.identifier.citedreference | P. A. Ott, Z. Hu, D. B. Keskin, S. A. Shukla, J. Sun, D. J. Bozym, W. Zhang, A. Luoma, A. Giobbie‐Hurder, L. Peter, C. Chen, O. Olive, T. A. Carter, S. Li, D. J. Lieb, T. Eisenhaure, E. Gjini, J. Stevens, W. J. Lane, I. Javeri, K. Nellaiappan, A. M. Salazar, H. Daley, M. Seaman, E. I. Buchbinder, C. H. Yoon, M. Harden, N. Lennon, S. Gabriel, S. J. Rodig, D. H. Barouch, J. C. Aster, G. Getz, K. Wucherpfennig, D. Neuberg, J. Ritz, E. S. Lander, E. F. Fritsch, N. Hacohen, C. J. Wu, Nature 2017, 547, 217. | |
dc.identifier.citedreference | M. Shapira, M. Jolivet, R. Arnon, Int. J. Immunopharmacol. 1985, 7, 719. | |
dc.identifier.citedreference | N. F. Fairweather, V. A. Lyness, D. J. Maskell, Infect. Immun. 1987, 55, 2541. | |
dc.identifier.citedreference | M. I. van Poelgeest, M. J. Welters, E. M. van Esch, L. F. Stynenbosch, G. Kerpershoek, E. L. van Persijn van Meerten, M. van den Hende, M. J. Lowik, D. M. Berends‐van der Meer, L. M. Fathers, A. R. Valentijn, J. Oostendorp, G. J. Fleuren, C. J. Melief, G. G. Kenter, S. H. van der Burg, J. Transl. Med. 2013, 11, 88. | |
dc.identifier.citedreference | S. Kruse, M. Buchler, P. Uhl, M. Sauter, P. Scherer, T. C. T. Lan, S. Zottnick, A. Klevenz, R. Yang, F. Rosl, W. Mier, A. B. Riemer, OncoImmunology 2019, 8, 1524694. | |
dc.identifier.citedreference | L. Scheetz, P. Kadiyala, X. Sun, S. Son, A. H. Najafabadi, M. Aikins, P. R. Lowenstein, A. Schwendeman, M. G. Castro, J. J. Moon, Clin. Cancer Res. 2020. | |
dc.identifier.citedreference | R. S. Riley, C. H. June, R. Langer, M. J. Mitchell, Nat. Rev. Drug Discovery 2019, 18, 175. | |
dc.identifier.citedreference | S. Stevanovic, S. R. Helman, J. R. Wunderlich, M. M. Langhan, S. L. Doran, M. L. M. Kwong, R. P. T. Somerville, C. A. Klebanoff, U. S. Kammula, R. M. Sherry, J. C. Yang, S. A. Rosenberg, C. S. Hinrichs, Clin. Cancer Res. 2019, 25, 1486. | |
dc.identifier.citedreference | N. Maskey, N. Thapa, M. Maharjan, G. Shrestha, N. Maharjan, H. Cai, S. Liu, Cancer Manage. Res. 2019, 11, 7647. | |
dc.identifier.citedreference | J. Nam, S. Son, K. S. Park, W. Zou, L. D. Shea, J. J. Moon, Nat. Rev. Mater. 2019, 4, 398. | |
dc.identifier.citedreference | U. Sahin, O. Tureci, Science 2018, 359, 1355. | |
dc.identifier.citedreference | Z. Hu, P. A. Ott, C. J. Wu, Nat. Rev. Immunol. 2018, 18, 168. | |
dc.identifier.citedreference | P. Romero, J. Banchereau, N. Bhardwaj, M. Cockett, M. L. Disis, G. Dranoff, E. Gilboa, S. A. Hammond, R. Hershberg, A. J. Korman, P. Kvistborg, C. Melief, I. Mellman, A. K. Palucka, I. Redchenko, H. Robins, F. Sallusto, T. Schenkelberg, S. Schoenberger, J. Sosman, O. Tureci, B. Van den Eynde, W. Koff, G. Coukos, Sci. Transl. Med. 2016, 8, 334ps9. | |
dc.identifier.citedreference | A. Yang, E. Farmer, T. C. Wu, C. F. Hung, J. Biomed. Sci. 2016, 23, 75. | |
dc.identifier.citedreference | R. Kuai, L. J. Ochyl, K. S. Bahjat, A. Schwendeman, J. J. Moon, Nat. Mater. 2017, 16, 489. | |
dc.identifier.citedreference | P. C. Maciag, S. Radulovic, J. Rothman, Vaccine 2009, 27, 3975. | |
dc.identifier.citedreference | P. J. de Vos van Steenwijk, T. H. Ramwadhdoebe, M. J. Lowik, C. E. van der Minne, D. M. Berends‐van der Meer, L. M. Fathers, A. R. Valentijn, J. Oostendorp, G. J. Fleuren, B. W. Hellebrekers, M. J. Welters, M. I. van Poelgeest, C. J. Melief, G. G. Kenter, S. H. van der Burg, Cancer Immunol. Immunother. 2012, 61, 1485. | |
dc.identifier.citedreference | A. D. Santin, S. Bellone, M. Palmieri, A. Zanolini, A. Ravaggi, E. R. Siegel, J. J. Roman, S. Pecorelli, M. J. Cannon, J. Virol. 2008, 82, 1968. | |
dc.identifier.citedreference | L. K. Borysiewicz, A. Fiander, M. Nimako, S. Man, G. W. Wilkinson, D. Westmoreland, A. S. Evans, M. Adams, S. N. Stacey, M. E. Boursnell, E. Rutherford, J. K. Hickling, S. C. Inglis, Lancet 1996, 347, 1523. | |
dc.identifier.citedreference | D. A. Sewell, V. Shahabi, G. R. Gunn, 3rd, Z. K. P, M. E. Dominiecki, Y. Paterson, Cancer Res. 2004, 64, 8821. | |
dc.identifier.citedreference | A. Chabeda, R. J. R. Yanez, R. Lamprecht, A. E. Meyers, E. P. Rybicki, Hitzeroth, II, Papillomavirus Res. 2018, 5, 46. | |
dc.identifier.citedreference | H. Liu, K. D. Moynihan, Y. Zheng, G. L. Szeto, A. V. Li, B. Huang, D. S. Van Egeren, C. Park, D. J. Irvine, Nature 2014, 507, 519. | |
dc.identifier.citedreference | I. P. Nascimento, L. C. Leite, Braz. J. Med. Biol. Res. 2012, 45, 1102. | |
dc.identifier.citedreference | P. J. Baldwin, S. H. van der Burg, C. M. Boswell, R. Offringa, J. K. Hickling, J. Dobson, J. S. Roberts, J. A. Latimer, R. P. Moseley, N. Coleman, M. A. Stanley, J. C. Sterling, Clin. Cancer Res. 2003, 9, 5205. | |
dc.identifier.citedreference | A. M. Kaufmann, P. L. Stern, E. M. Rankin, H. Sommer, V. Nuessler, A. Schneider, M. Adams, T. S. Onon, T. Bauknecht, U. Wagner, K. Kroon, J. Hickling, C. M. Boswell, S. N. Stacey, H. C. Kitchener, J. Gillard, J. Wanders, J. S. Roberts, H. Zwierzina, Clin. Cancer Res. 2002, 8, 3676. | |
dc.identifier.citedreference | E. Medina, C. A. Guzman, Vaccine 2001, 19, 1573. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.